{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:21:39Z","timestamp":1775193699016,"version":"3.50.1"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI13C0826"],"award-info":[{"award-number":["HI13C0826"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003624","name":"Ministry of Agriculture, Food and Rural Affairs","doi-asserted-by":"publisher","award":["MAFRA716002-7"],"award-info":[{"award-number":["MAFRA716002-7"]}],"id":[{"id":"10.13039\/501100003624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF2015R1D1A4A01016640"],"award-info":[{"award-number":["NRF2015R1D1A4A01016640"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00116","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T04:15:52Z","timestamp":1517458552000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Pan-Influenza A Protection by Prime\u2013Boost Vaccination with Cold-Adapted Live-Attenuated Influenza Vaccine in a Mouse Model"],"prefix":"10.3389","volume":"9","author":[{"given":"Yo Han","family":"Jang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Ho","family":"Byun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahyun","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Yoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baik Lin","family":"Seong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/S0140-6736(03)14854-4","article-title":"Influenza","volume":"362","author":"Nicholson","year":"2003","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines","volume":"14","author":"Krammer","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"B3","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1038\/nm1141","article-title":"Influenza: old and new threats","volume":"10","author":"Palese","year":"2004","journal-title":"Nat Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.chom.2015.10.003","article-title":"The quest for a universal flu vaccine: headless HA 2.0","volume":"18","author":"Krammer","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B5","doi-asserted-by":"publisher","first-page":"200fs234","DOI":"10.1126\/scitranslmed.3007118","article-title":"Universal flu vaccines: primum non nocere","volume":"5","author":"Crowe","year":"2013","journal-title":"Sci Transl Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"200ra114","DOI":"10.1126\/scitranslmed.3006366","article-title":"Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease","volume":"5","author":"Khurana","year":"2013","journal-title":"Sci Transl Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1016\/j.vaccine.2014.07.059","article-title":"Influenza A virus hemagglutinin protein subunit vaccine elicits vaccine-associated enhanced respiratory disease in pigs","volume":"32","author":"Rajao","year":"2014","journal-title":"Vaccine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"Ekiert","year":"2011","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1073\/pnas.1319058110","article-title":"A common solution to group 2 influenza virus neutralization","volume":"111","author":"Friesen","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e1005702","DOI":"10.1371\/journal.ppat.1005702","article-title":"Two escape mechanisms of influenza A virus to a broadly neutralizing stalk-binding antibody","volume":"12","author":"Chai","year":"2016","journal-title":"PLoS Pathog"},{"key":"B11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41541-017-0026-4","article-title":"A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies","volume":"2","author":"Nachbagauer","year":"2017","journal-title":"npj Vaccines"},{"key":"B12","doi-asserted-by":"publisher","first-page":"7437","DOI":"10.4049\/jimmunol.166.12.7437","article-title":"Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells","volume":"166","author":"Benton","year":"2001","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"8067","DOI":"10.1016\/j.vaccine.2007.09.012","article-title":"Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccine","volume":"25","author":"Seo","year":"2007","journal-title":"Vaccine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3349\/ymj.2013.54.2.271","article-title":"Cross-protective immune responses elicited by live attenuated influenza vaccines","volume":"54","author":"Jang","year":"2013","journal-title":"Yonsei Med J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.it.2014.06.004","article-title":"T cell mediated immunity to influenza: mechanisms of viral control","volume":"35","author":"La Gruta","year":"2014","journal-title":"Trends Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.chom.2017.02.007","article-title":"Generation of a live attenuated influenza vaccine that elicits broad protection in mice and ferrets","volume":"21","author":"Wang","year":"2017","journal-title":"Cell Host Microbe"},{"key":"B18","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/infdis\/141.3.362","article-title":"Gene composition of high-yielding influenza vaccine strains obtained by recombination","volume":"141","author":"Baez","year":"1980","journal-title":"J Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1084\/jem.98.6.641","article-title":"Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus","volume":"98","author":"Davenport","year":"1953","journal-title":"J Exp Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.4049\/jimmunol.0900398","article-title":"Original antigenic sin responses to influenza viruses","volume":"183","author":"Kim","year":"2009","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.vaccine.2005.10.051","article-title":"Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus","volume":"24","author":"Lee","year":"2006","journal-title":"Vaccine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.vaccine.2016.01.053","article-title":"Genetic analysis of attenuation markers of cold-adapted X-31 influenza live vaccine donor strain","volume":"34","author":"Jang","year":"2016","journal-title":"Vaccine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.vaccine.2012.12.072","article-title":"Cold-adapted X-31 live attenuated 2009 pandemic H1N1 influenza vaccine elicits protective immune responses in mice and ferrets","volume":"31","author":"Jang","year":"2013","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1016\/j.vaccine.2013.05.080","article-title":"Immunogenicity and protective efficacy of cold-adapted X-31 live attenuated pre-pandemic H5N1 influenza vaccines","volume":"31","author":"Jang","year":"2013","journal-title":"Vaccine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.vaccine.2013.12.002","article-title":"Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A\/X-31 and B\/Lee\/40 donor strains","volume":"32","author":"Jang","year":"2014","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jviromet.2013.10.035","article-title":"High-yield soluble expression of recombinant influenza virus antigens from Escherichia coli and their potential uses in diagnosis","volume":"196","author":"Jang","year":"2014","journal-title":"J Virol Methods"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e102339","DOI":"10.1371\/journal.pone.0102339","article-title":"Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus","volume":"9","author":"Isakova-Sivak","year":"2014","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.1128\/JVI.07149-11","article-title":"Cold-adapted pandemic 2009 H1N1 influenza virus live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses","volume":"86","author":"Jang","year":"2012","journal-title":"J Virol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.virol.2017.01.021","article-title":"Cell-cultured, live attenuated, X-31ca-based H5N1 pre-pandemic influenza vaccine","volume":"504","author":"Lee","year":"2017","journal-title":"Virology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/vaccines3010105","article-title":"M2e-based universal influenza A vaccines","volume":"3","author":"Deng","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e1005578","DOI":"10.1371\/journal.ppat.1005578","article-title":"Broadly-reactive neutralizing and non-neutralizing antibodies directed against the H7 influenza virus hemagglutinin reveal divergent mechanisms of protection","volume":"12","author":"Tan","year":"2016","journal-title":"PLoS Pathog"},{"key":"B32","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/infdis\/jiw629","article-title":"Induction of H7N9-cross-reactive antibody-dependent cellular cytotoxicity antibodies by human seasonal influenza A viruses that are directed toward the nucleoprotein","volume":"215","author":"Jegaskanda","year":"2017","journal-title":"J Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.1371\/journal.pmed.0030360","article-title":"Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets","volume":"3","author":"Suguitan","year":"2006","journal-title":"PLoS Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.antiviral.2012.01.001","article-title":"Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice","volume":"93","author":"Shi","year":"2012","journal-title":"Antiviral Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"13751","DOI":"10.1073\/pnas.0912458109","article-title":"Strategies to alleviate original antigenic sin responses to influenza viruses","volume":"109","author":"Kim","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B36","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ebiom.2016.04.029","article-title":"What lies beneath: antibody dependent natural killer cell activation by antibodies to internal influenza virus proteins","volume":"8","author":"Vanderven","year":"2016","journal-title":"EBioMedicine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0264-410X(99)00183-8","article-title":"Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children","volume":"18","author":"Boyce","year":"1999","journal-title":"Vaccine"},{"key":"B38","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0264-410X(99)00334-5","article-title":"Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses","volume":"18","author":"Treanor","year":"1999","journal-title":"Vaccine"},{"key":"B39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1750-2659.2010.00183.x","article-title":"The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults","volume":"5","author":"Ambrose","year":"2011","journal-title":"Influenza Other Respi Viruses"},{"key":"B40","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.4049\/jimmunol.105.6.1477","article-title":"Specificity of respiratory secretion antibody against influenza virus","volume":"105","author":"Waldman","year":"1970","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/eji.1830140414","article-title":"Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity","volume":"14","author":"Liew","year":"1984","journal-title":"Eur J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/0264-410X(90)90250-P","article-title":"Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza","volume":"8","author":"Tamura","year":"1990","journal-title":"Vaccine"},{"key":"B43","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"Huber","year":"2001","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e17377","DOI":"10.1371\/journal.pone.0017377","article-title":"A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection","volume":"6","author":"O\u2019Brien","year":"2011","journal-title":"PLoS One"},{"key":"B45","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/infdis\/148.5.785","article-title":"Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells","volume":"148","author":"Hashimoto","year":"1983","journal-title":"J Infect Dis"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1128\/JVI.01210-07","article-title":"Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice","volume":"82","author":"Fujisawa","year":"2008","journal-title":"J Virol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1128\/JVI.03030-12","article-title":"Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques","volume":"87","author":"Jegaskanda","year":"2013","journal-title":"J Virol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/jlb.37.5.597","article-title":"Reactivity of anti-asialo GM1 serum with tumoricidal and non-tumoricidal mouse macrophages","volume":"37","author":"Wiltrout","year":"1985","journal-title":"J Leukoc Biol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1349-7006.1996.tb00241.x","article-title":"Murine asialo GM1+CD8+ T cells as novel interleukin-12-responsive killer T cell precursors","volume":"87","author":"Lee","year":"1996","journal-title":"Jpn J Cancer Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1172\/JCI8082","article-title":"Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection","volume":"104","author":"Trambley","year":"1999","journal-title":"J Clin Invest"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.4049\/jimmunol.164.4.2009","article-title":"NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells","volume":"164","author":"Slifka","year":"2000","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1089\/dna.2004.23.549","article-title":"Antitumor activity of eosinophils activated by IL-5 and eotaxin against hepatocellular carcinoma","volume":"23","author":"Kataoka","year":"2004","journal-title":"DNA Cell Biol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.4049\/jimmunol.1100370","article-title":"NK cell-depleting anti-asialo GM1 antibody exhibits a lethal off-target effect on basophils in vivo","volume":"186","author":"Nishikado","year":"2011","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.7774\/cevr.2013.2.2.71","article-title":"Toward a universal influenza vaccine: from the perspective of protective efficacy","volume":"2","author":"Jang","year":"2013","journal-title":"Clin Exp Vaccine Res"},{"key":"B55","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1743-422X-10-244","article-title":"Cross-reactive human B cell and T cell epitopes between influenza A and B viruses","volume":"10","author":"Terajima","year":"2013","journal-title":"Virol J"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3390\/v20801530","article-title":"Animal models for influenza virus pathogenesis and transmission","volume":"2","author":"Bouvier","year":"2010","journal-title":"Viruses"},{"key":"B57","doi-asserted-by":"publisher","first-page":"20365","DOI":"10.1073\/pnas.0911580106","article-title":"Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population","volume":"106","author":"Greenbaum","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B58","doi-asserted-by":"publisher","first-page":"12599","DOI":"10.1073\/pnas.1007270107","article-title":"Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses","volume":"107","author":"Gras","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B59","doi-asserted-by":"publisher","first-page":"316ra192","DOI":"10.1126\/scitranslmed.aad0522","article-title":"Immune history profoundly affects broadly protective B cell responses to influenza","volume":"7","author":"Andrews","year":"2015","journal-title":"Sci Transl Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/oxfordjournals.aje.a120543","article-title":"Homologous and heterologous resistance to rhinovirus common cold","volume":"82","author":"Fleet","year":"1965","journal-title":"Am J Epidemiol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1093\/cid\/cis307","article-title":"Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine","volume":"54","author":"Cowling","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e397","DOI":"10.1542\/peds.2004-2258","article-title":"Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial","volume":"116","author":"Piedra","year":"2005","journal-title":"Pediatrics"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1086\/648405","article-title":"A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A\/Vietnam\/1203\/2004, in mice","volume":"200","author":"Xie","year":"2009","journal-title":"J Infect Dis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e02259","DOI":"10.1128\/JVI.02259-16","article-title":"Evaluation of the immune responses to and cross-protective efficacy of Eurasian H7 avian influenza viruses","volume":"91","author":"Kwon","year":"2017","journal-title":"J Virol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00116\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T20:05:48Z","timestamp":1693512348000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00116\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":64,"alternative-id":["10.3389\/fimmu.2018.00116"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00116","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,1]]},"article-number":"116"}}